Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance NASDAQ BLPH opened at $0.04 on Friday. Bellerophon Therapeutics has a twelve month low of $0.03 and a twelve month high […]
More Stories
QRAFT AI-Enhanced U.S. Large Cap ETF (QRFT) To Go Ex-Dividend on September 24th
QRAFT AI-Enhanced U.S. Large Cap ETF (NYSEARCA:QRFT – Get Free Report) announced a dividend on Monday, September 23rd, NASDAQ reports....
DNP Select Income Fund Inc. (NYSE:DNP) to Issue $0.07 Monthly Dividend
DNP Select Income Fund Inc. (NYSE:DNP – Get Free Report) announced a monthly dividend on Monday, September 23rd, Wall Street...
Bancreek International Large Cap ETF (BCIL) To Go Ex-Dividend on September 24th
Bancreek International Large Cap ETF (NYSEARCA:BCIL – Get Free Report) declared a dividend on Monday, September 23rd, NASDAQ reports. Shareholders...
Direxion Daily AAPL Bull 2X Shares (AAPU) To Go Ex-Dividend on September 24th
Direxion Daily AAPL Bull 2X Shares (NASDAQ:AAPU – Get Free Report) declared a quarterly dividend on Monday, September 23rd, NASDAQ...
Direxion Daily META Bear 1X Shares (NASDAQ:METD) Raises Dividend to $0.18 Per Share
Direxion Daily META Bear 1X Shares (NASDAQ:METD – Get Free Report) declared a quarterly dividend on Monday, September 23rd, NASDAQ...
AstraZeneca PLC (NASDAQ:AZN) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of AstraZeneca PLC (NASDAQ:AZN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the...